Therapeutic potential of protein and adjuvant vaccinations on tumour growth
- 14 March 2001
- Vol. 19 (17-19) , 2583-2589
- https://doi.org/10.1016/s0264-410x(00)00486-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Advances in vaccine adjuvantsNature Biotechnology, 1999
- Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of VaccinesMethods, 1999
- Experimental vaccine strategies for cancer immunotherapyJournal of Biomedical Science, 1998
- Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory ReceptorImmunity, 1997
- Analysis of p53 Serum Antibodies in Patients With Head and Neck Squamous Cell CarcinomaJNCI Journal of the National Cancer Institute, 1996
- Serological response to HPV16 in CIN-III and cervical-cancer patients. Case-control studies in Spain and ColombiaInternational Journal of Cancer, 1996
- Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapyCritical Reviews in Oncology/Hematology, 1994
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Tumor Eradication by Adoptive Transfer of Cytototic T LymphocytesPublished by Elsevier ,1992
- MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen bindingNature, 1991